Heron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by StockNews.com
Heron Therapeutics (NASDAQ:HRTX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Saturday. Separately, Needham & Company LLC reiterated a “buy” rating and issued a $4.00 price target on shares of Heron Therapeutics in a research note on Friday, […]
Heron Therapeutics (NASDAQ:HRTX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Saturday. Separately, Needham & Company LLC reiterated a “buy” rating and issued a $4.00 price target on shares of Heron Therapeutics in a research note on Friday, […]
